# Niagen Bioscience, Inc.: Form 8-K, filed Feb 26, 2026

- Company: [Niagen Bioscience, Inc.](/companies/nage.md) (CIK 1386570)
- Form: 8-K
- Filed: 2026-02-26
- Accepted by EDGAR: Feb 26, 2026, 07:02 ET
- Period: 2026-02-24
- Accession: 0001386570-26-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/cdxc-20260224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/cdxc-20260224.htm

Filed Feb 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001386570-26-000003. Last ingested by Listed: Nov 4, 2026, 16:21 ET. No prices; not investment advice.
